Literature DB >> 7878004

Regulation of human retroviral latency by the NF-kappa B/I kappa B family: inhibition of human immunodeficiency virus replication by I kappa B through a Rev-dependent mechanism.

B Y Wu1, C Woffendin, C S Duckett, T Ohno, G J Nabel.   

Abstract

The cellular transcription factor NF-kappa B stimulates human immunodeficiency virus type 1 (HIV-1) transcriptional initiation, but its role in the retroviral life cycle has not been fully defined. In this report, we show that I kappa B alpha acts as a cellular inhibitor of human retroviral replication through a discrete mechanism, independent of its effect on HIV transcription. I kappa B alpha inhibited HIV replication and gp160 expression by negatively regulating Rev function, most likely acting through a cellular factor involved in Rev transactivation. A similar effect was observed with human T leukemia virus I, in which I kappa B alpha inhibited Rex function. In contrast, no effect was observed on the replication of a DNA virus, adenovirus type 5. The NF-kappa B/I kappa B regulatory pathway therefore modulates human retroviral replication by regulating a program of cellular gene expression required for several steps in the viral life cycle, including not only viral transcription but also RNA export. This interaction between cellular and viral gene products suggests that NF-kappa B plays a broader role in the regulation of human retroviral replication, providing a previously unrecognized link between two important regulators of HIV gene expression and common NF-kappa B-dependent programs of gene expression used by human retroviruses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7878004      PMCID: PMC42543          DOI: 10.1073/pnas.92.5.1480

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Comparative analysis of the HTLV-I Rex and HIV-1 Rev trans-regulatory proteins and their RNA response elements.

Authors:  S M Hanly; L T Rimsky; M H Malim; J H Kim; J Hauber; M Duc Dodon; S Y Le; J V Maizel; B R Cullen; W C Greene
Journal:  Genes Dev       Date:  1989-10       Impact factor: 11.361

2.  Trans-dominant inactivation of HTLV-I and HIV-1 gene expression by mutation of the HTLV-I Rex transactivator.

Authors:  L Rimsky; M D Dodon; E P Dixon; W C Greene
Journal:  Nature       Date:  1989-10-05       Impact factor: 49.962

3.  Two cis-acting elements responsible for posttranscriptional trans-regulation of gene expression of human T-cell leukemia virus type I.

Authors:  M Seiki; J Inoue; M Hidaka; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

4.  Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif.

Authors:  T J Hope; X J Huang; D McDonald; T G Parslow
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

5.  Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B.

Authors:  S Ghosh; D Baltimore
Journal:  Nature       Date:  1990-04-12       Impact factor: 49.962

6.  Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation.

Authors:  M F Laspia; A P Rice; M B Mathews
Journal:  Genes Dev       Date:  1990-12       Impact factor: 11.361

7.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor.

Authors:  P A Baeuerle; D Baltimore
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

8.  Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells.

Authors:  J Liu; C Woffendin; Z Y Yang; G J Nabel
Journal:  Gene Ther       Date:  1994-01       Impact factor: 5.250

9.  A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB.

Authors:  P A Baeuerle; D Baltimore
Journal:  Genes Dev       Date:  1989-11       Impact factor: 11.361

10.  The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV.

Authors:  E Böhnlein; J W Lowenthal; M Siekevitz; D W Ballard; B R Franza; W C Greene
Journal:  Cell       Date:  1988-06-03       Impact factor: 41.582

View more
  15 in total

1.  Export of hepatitis B virus RNA on a Rev-like pathway: inhibition by the regenerating liver inhibitory factor IkappaB alpha.

Authors:  J Roth; M Dobbelstein
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription.

Authors:  Z Li; G J Nabel
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

3.  HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator.

Authors:  L K Felzien; C Woffendin; M O Hottiger; R A Subbramanian; E A Cohen; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

4.  NF-kappaB cis-acting motifs of the human immunodeficiency virus (HIV) long terminal repeat regulate HIV transcription in human macrophages.

Authors:  S Asin; G D Bren; E M Carmona; N J Solan; C V Paya
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  A role for casein kinase II phosphorylation in the regulation of IRF-1 transcriptional activity.

Authors:  R Lin; J Hiscott
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

6.  In vivo transcriptional regulation of the human immunodeficiency virus in the central nervous system in transgenic mice.

Authors:  J Kurth; J M Buzy; L Lindstrom; J E Clements
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 7.  Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.

Authors:  Jean-François Gélinas; Deborah R Gill; Stephen C Hyde
Journal:  Microbiol Mol Biol Rev       Date:  2018-01-10       Impact factor: 11.056

8.  Ikappakappa mediates NF-kappaB activation in human immunodeficiency virus-infected cells.

Authors:  S Asin; J A Taylor; S Trushin; G Bren; C V Paya
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

9.  Distinct domains of IkappaB-alpha inhibit human immunodeficiency virus type 1 replication through NF-kappaB and Rev.

Authors:  B Y Wu; C Woffendin; I MacLachlan; G J Nabel
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

10.  The Ras-Raf pathway is activated in human immunodeficiency virus-infected monocytes and particpates in the activation of NF-kappa B.

Authors:  L Folgueira; A Algeciras; W S MacMorran; G D Bren; C V Paya
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.